Back to results
US 5,962,725 AGranted
Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
AssigneesAgouron Pharmaceuticals, Inc., Japan Tobacco Inc.
InventorsMichael E. Deason, Kathleen R. Whitten
Life of this patent
Estimating the term…
Abstract
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive compounds and intermediates.
Claims2
A compound of formula:
- ##STR76## wherein:
- R.sub.1 is:
- a heteroaryl group;
- a group of formula ##STR77## heterocycloalkyl group, or O--R.sub.6, where R.sub.6 is an alkyl group, an aralkyl group, or an aryl group;
- a group of formula ##STR78## wherein each R.sub.3 is independently an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, or a heteroaryl group;
- or
- a group of formula ##STR79## wherein R.sub.4 and each R.sub.5 are independently an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, or a heteroaryl group;
- and
- X is Cl;
- or a pharmaceutically acceptable salt or solvate of said compound.
7 more elements
Dependencies are inferred from the claim text.